Rebuttal and response to: “The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?” by Ahmet Emre Eskazan, Muhlis Cem Ar and Teoman Soysal

✍ Scribed by Alwan, Alaa Fadhil

• Book ID: 125834368
• Publisher: Informa plc
• Year: 2014
• Tongue: English
• Weight: 395 KB
• Volume: 56
• Category: Article
• ISSN: 1042-8194
• DOI: 10.3109/10428194.2014.947757